New Key Statistics Module, Z-Score and F-Score
OCSE:VIRO Key Ratios
| Market Cap kr M | 37.70 |
| Enterprise Value kr M | 34.27 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.04 |
| Price/Sales | 4.61 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 6.00 |
| EPS (TTM) kr | -2.20 |
| Beneish M-Score | -2.28 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 7.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.58 |
| EV-to-EBITDA | -2.58 |
| PEG | -- |
| Shares Outstanding M | 6.44 |
| Net Margin (%) | -190.20 |
| Operating Margin % | -193.03 |
| Pre-tax Margin (%) | -203.06 |
| Quick Ratio | 8.60 |
| Current Ratio | 11.74 |
| ROA % (ttm) | -72.04 |
| ROE % (ttm) | -116.26 |
| ROIC % (ttm) | -178.87 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.49 |
OCSE:VIRO Number of Guru Trades
OCSE:VIRO Volume of Guru Trades
Gurus Latest Trades with OCSE:VIRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OCSE:VIRO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers